Nasdaq Top Companies List by Market Cap as of August 2026
Nasdaq Top Companies List by Market Cap as of August 2026, Nasdaq Biggest 500 Companies List by Market Cap, Nasdaq Largest 500 Companies List by market cap as of August 2026.-
World Rank (Aug-2026)9,487Market Cap (Aug-2026)0.950 Billion USDWorld Rank (Jan-05-2024)15,870Market Cap (Jan-05-2024)0.295 Billion USDWorld Rank (Jul-30-2023)17,412Market Cap (Jul-30-2023)0.226 Billion USDWorld Rank (Dec-25-2022)19,700Market Cap (Dec-25-2022)0.146 Billion USDWorld Rank (Jan-07-2022)19,130Market Cap (Jan-07-2022)0.20 Billion USDAnnual Revenue in USD518 Million USDAnnual Net Income in USD20 Million USDAnnual Results for Period EndingFor year ending December-2025Company Website
-
Geron Corporation
World Rank (Aug-2026)9,506Market Cap (Aug-2026)0.944 Billion USDWorld Rank (Jan-05-2024)7,962Market Cap (Jan-05-2024)1.135 Billion USDWorld Rank (Jul-30-2023)6,549Market Cap (Jul-30-2023)1.618 Billion USDWorld Rank (Dec-25-2022)9,612Market Cap (Dec-25-2022)0.797 Billion USDWorld Rank (Jan-07-2022)15,170Market Cap (Jan-07-2022)0.38 Billion USDAnnual Net Income in USD-84 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileGeron Corporation is a Late Stage Clinical Biopharmaceutical company focused on the development and potential commercialization of a first in class telomerase inhibitor, imetelstat, an innovative therapeutic for hematologic myeloid malignancies. The headquarters is in USA.
Facts About CompanyGeron Corporation Annual Total Revenue for year ending Dec-2022 was 0.5 million USD and and Net loss for year ending Dec-2022 was -141 million USD.
Geron Corporation Annual Total Revenue for year ending Dec-2021 was 1.3 million USD and and Net loss for year ending Dec-2021 was =116 million USD.
As on 2022, Geron Corporation has 107 employees.
Company WebsiteWikipedia -
Oxford Lane Capital
World Rank (Aug-2026)9,535Market Cap (Aug-2026)0.938 Billion USDWorld Rank (Jan-05-2024)8,211Market Cap (Jan-05-2024)1.079 Billion USDWorld Rank (Jul-30-2023)8,945Market Cap (Jul-30-2023)0.956 Billion USDWorld Rank (Dec-25-2022)9,393Market Cap (Dec-25-2022)0.829 Billion USDWorld Rank (Jan-07-2022)9,462Market Cap (Jan-07-2022)1.00 Billion USDAnnual Revenue in USD130 Million USDAnnual Net Income in USD125 Million USDAnnual Results for Period EndingMar-2022 ending yearCompany ProfileOxford Lane Capital Annual Total Revenue for year ending Dec-2022 was -158 million USD and and Net loss for year ending Dec-2022 was -171 million USD.
Oxford Lane Capital Annual Total Revenue for year ending Dec-2021 was 130 million USD and and Net Income for year ending Dec-2021 was 125 million USD.
As on 2022, Oxford Lane Capital has 824 employees.
Facts About CompanyOxford Lane Capital Annual Total Revenue for year ending Dec-2022 was -158 million USD and and Net loss for year ending Dec-2022 was -171 million USD.
Company Website -
First Community Bankshares
World Rank (Aug-2026)9,550Market Cap (Aug-2026)0.936 Billion USDWorld Rank (Jan-05-2024)10,802Market Cap (Jan-05-2024)0.674 Billion USDWorld Rank (Jul-30-2023)11,182Market Cap (Jul-30-2023)0.641 Billion USDWorld Rank (Dec-25-2022)11,628Market Cap (Dec-25-2022)0.565 Billion USDWorld Rank (Jan-07-2022)12,365Market Cap (Jan-07-2022)0.60 Billion USDAnnual Net Income in USD49 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileFirst Community Bankshares is a Financial Holding company. The company annual revenue is 137 million USD and 519 employees as on 2020. The Company reported consolidated assets of 2.80 billion USD as of December 31, 2019. The headquarters is in USA.Company Website -
Alpha and Omega Semiconductor
World Rank (Aug-2026)9,568Market Cap (Aug-2026)0.931 Billion USDWorld Rank (Jan-05-2024)9,864Market Cap (Jan-05-2024)0.787 Billion USDWorld Rank (Jul-30-2023)9,485Market Cap (Jul-30-2023)0.865 Billion USDWorld Rank (Dec-25-2022)9,680Market Cap (Dec-25-2022)0.787 Billion USDWorld Rank (Jan-07-2022)7,648Market Cap (Jan-07-2022)1.43 Billion USDAnnual Revenue in USD679 Million USDAnnual Net Income in USD-42 Million USDAnnual Results for Period EndingFor year ending June-2026Company ProfileAlpha and Omega Semiconductor is committed to excellence in design, manufacturing and responsiveness to customers through the continued development of new technologies, products and innovative solutions company. It portfolio of products targets high volume applications, including but not limited to portable computers, flat panel TVs, LED lighting, smart phones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. The headquarters is in USA.Company Website -
Olema Pharmaceuticals Inc.
World Rank (Aug-2026)9,573Market Cap (Aug-2026)0.930 Billion USDWorld Rank (Jan-05-2024)10,291Market Cap (Jan-05-2024)0.733 Billion USDWorld Rank (Jul-30-2023)15,099Market Cap (Jul-30-2023)0.343 Billion USDWorld Rank (Dec-25-2022)21,255Market Cap (Dec-25-2022)0.107 Billion USDWorld Rank (Jan-07-2022)16,820Market Cap (Jan-07-2022)0.29 Billion USDAnnual Net Income in USD-162 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileOlema Pharmaceuticals is a Clinical Stage Biopharmaceutical company. It is committed to the discovery, development and commercialization of a transformational generation of targeted therapies for women’s cancers. The headquarters is in USA.Company Website -
Boston Private Financial Holdings
World Rank (Aug-2026)9,575World Rank (Jan-05-2024)9,575World Rank (Jul-30-2023)9,575World Rank (Dec-25-2022)9,575World Rank (Jan-07-2022)9,575Annual Revenue in USD327 Million USDAnnual Net Income in USD45 Million USDAnnual Results for Period EndingFor year ending December-2020Company ProfileBanking and financial services company with headquarters is in Massachusetts, USA.Company Website -
Arbutus Biopharma Corporation
World Rank (Aug-2026)9,596Market Cap (Aug-2026)0.924 Billion USDWorld Rank (Jan-05-2024)13,671Market Cap (Jan-05-2024)0.419 Billion USDWorld Rank (Jul-30-2023)14,777Market Cap (Jul-30-2023)0.361 Billion USDWorld Rank (Dec-25-2022)14,340Market Cap (Dec-25-2022)0.374 Billion USDWorld Rank (Jan-07-2022)13,918Market Cap (Jan-07-2022)0.47 Billion USDAnnual Revenue in USD14 Million USDAnnual Net Income in USD-34 Million USDAnnual Results for Period EndingFor year ending December-2025Company WebsiteWikipedia -
Collegium Pharmaceutical
World Rank (Aug-2026)9,617Market Cap (Aug-2026)0.919 Billion USDWorld Rank (Jan-05-2024)8,100Market Cap (Jan-05-2024)1.103 Billion USDWorld Rank (Jul-30-2023)10,025Market Cap (Jul-30-2023)0.785 Billion USDWorld Rank (Dec-25-2022)9,777Market Cap (Dec-25-2022)0.771 Billion USDWorld Rank (Jan-07-2022)11,744Market Cap (Jan-07-2022)0.66 Billion USDAnnual Revenue in USD781 Million USDAnnual Net Income in USD63 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileCollegium Pharmaceutical is a Specialty Pharmaceutical company committed to being the leader in responsible pain management. It has been focused on developing and commercializing new medicines for pain management that reflect its core values and commitment to people suffering from pain, providers and communities. The headquarters is in USA.
Company Website -
Arco Platform
World Rank (Aug-2026)9,619World Rank (Jan-05-2024)9,619World Rank (Jul-30-2023)9,619Market Cap (Jul-30-2023)0.844 Billion USDWorld Rank (Dec-25-2022)9,834Market Cap (Dec-25-2022)0.766 Billion USDWorld Rank (Jan-07-2022)8,996Market Cap (Jan-07-2022)1.08 Billion USDAnnual Revenue in USD242 Million USDAnnual Net Income in USD-31 Million USDAnnual Results for Period EndingDec-2021 ending yearCompany Website